Multiple Sclerosis Market Vendor Analysis, Forecast and Investment Trends to 2023

Submitted by: Submitted by

Views: 10

Words: 998

Pages: 4

Category: Business and Industry

Date Submitted: 04/28/2016 12:12 AM

Report This Essay

Multiple Sclerosis Market Size, Share, Trends, Company Profiles, Demand,

Insights, Analysis, Research, Report, Opportunities, Segmentation and

Forecast To 2023

Multiple sclerosis (MS) is an inflammatory disease in which the myelin sheaths around the axons

of the brain and spinal cord are damaged, leading to demyelination and a wide range of signs and

symptoms. MS affects 2.5 million people worldwide each year and is the most debilitating

neurological disease in young adults.

GlobalData epidemiologists expect that the number of prevalent and incident cases of MS will

increase during the forecast period (2013-2023) in the 10MM. In 2013, GlobalData

epidemiologists forecast that there were a total of 904,908 prevalent cases of MS in the 10MM,

and by 2023 GlobalData epidemiologists forecast that the number of prevalent cases will grow to

940,413 prevalent cases. During the forecast period, India will have the highest annual growth

rate (AGR) at 1.99%, Spain will have the second highest (AGR: 1.05%), and China will have the

third highest (AGR: 0.93%).

Complete report is available at: http://www.radiantinsights.com/research/epicast-reportmultiple-sclerosis-epidemiology-forecast-to-2023

GlobalData epidemiologists used country-specific sources published by peer-reviewed journals

to estimate the incidence and prevalence of MS in each of the 10MM. To provide a thorough

description of the MS patient population in each country, GlobalData epidemiologists segmented

MS incident and prevalent cases by age and sex, both of which strongly affect the epidemiology

of MS. Moreover, cases are segmented into three common sub-types: relapsing-remitting MS,

primary progressive MS, and secondary progressive MS. A major strength of this analysis is that

the forecast methodology was consistent across the 10MM to allow for a meaningful comparison

of the patient populations in each country.

Scope

- The Multiple Sclerosis (MS) EpiCast Report provides an overview of the...